BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,998.74
      -0.38%
      US Tech 100
      20,208.00
      -0.81%
      Dow Jones
      44,722.06
      -0.31%
      Brent Oil
      72.375
      -0.10%
      Bitcoin
      96,629.94
      5.07%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Menlo Therapeutics Inc (MNLO) Quote

      Menlo Therapeutics Inc

      Menlo Therapeutics Inc (MNLO)

      NASDAQ
      1.35
      0.00
      (0.00%)
      At close: November 27 4:00PM
      Delayed by 15 minutes
      1.35
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.35
      Bid
      1.36
      Ask
      1.37
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      18.842M
      Previous Close
      1.35
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      13,957,000
      Dividend Yield
      -
      PE Ratio
      -1.45
      Earnings Per Share (EPS)
      -2.04
      Revenue
      424k
      Net Profit
      -28.45M

      About Menlo Therapeutics Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      vynetherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      MNLO Latest News

      More News

      Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement

      The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Menlo Therapeutics Inc. Securities Settlement: SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF...

      May 22 2020
      Business Wire

      Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

      REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the...

      March 03 2020
      GlobeNewswire Inc.

      Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

      REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial...

      February 26 2020
      GlobeNewswire Inc.

      Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...

      REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced it will host a conference call and webcast...

      February 25 2020
      GlobeNewswire Inc.

      Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...

      REDWOOD CITY, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

      February 05 2020
      GlobeNewswire Inc.

      Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference

      REDWOOD CITY, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

      November 27 2019
      GlobeNewswire Inc.

      SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.

      SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire NEW YORK, Nov. 12, 2019 NEW YORK, Nov. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

      November 12 2019
      PR Newswire (US)

      Menlo Therapeutics Reports Third Quarter 2019 Financial Results and Provides Program Updates

      REDWOOD CITY, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

      October 31 2019
      GlobeNewswire Inc.

      Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials of Serlopitant in Prurigo Nodularis

      - Pivotal results expected in March/April 2020 - - Details of the program to be reviewed at company’s Investor Day today in NY - REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo...

      October 29 2019
      GlobeNewswire Inc.

      Menlo Therapeutics to Host Investor Day October 29, 2019

      -Management to Review Late Stage Development, NDA-readiness and Commercial Opportunity of Serlopitant- -Discussion to Feature two Prominent Key Opinion Leaders Well Versed in the Unmet Needs of...

      October 22 2019
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BMRABiomerica Inc
      $ 0.4789
      (48.68%)
      		8.7M
      BSLKBolt Projects Holdings Inc
      $ 0.358
      (20.95%)
      		53.95k
      CRKNCrown Electrokinetics Corporation
      $ 0.334
      (19.67%)
      		8.4M
      PGHLPrimega Group Holdings Ltd
      $ 1.93
      (16.97%)
      		8.65M
      EDSAEdesa Biotech Inc
      $ 2.60
      (13.04%)
      		827
      APLTApplied Therapeutics Inc
      $ 2.11
      (-75.38%)
      		7.09M
      CMAXCareMax Inc
      $ 0.2775
      (-34.16%)
      		420.01k
      TCBPTC BioPharm Holdings PLC
      $ 0.40
      (-33.33%)
      		136.97k
      TOIIWOncology Institute Inc
      $ 0.0135
      (-28.57%)
      		5.82k
      PROCProcaps Group SA
      $ 1.74
      (-16.75%)
      		16.03k
      IDAIT Stamp Inc
      $ 0.7299
      (-13.11%)
      		8.73M
      BMRABiomerica Inc
      $ 0.4786
      (48.59%)
      		8.71M
      PGHLPrimega Group Holdings Ltd
      $ 1.92
      (16.36%)
      		8.65M
      CRKNCrown Electrokinetics Corporation
      $ 0.334
      (19.67%)
      		8.4M
      APLTApplied Therapeutics Inc
      $ 2.11
      (-75.38%)
      		7.09M

      Discussion

      View Full Feed
      pos_stock_hoarder pos_stock_hoarder 4 minutes ago
      Gobble goggle. Have a good holiday everyone!
      skitahoe skitahoe 4 minutes ago
      I certainly don't know, but as I understand it the European authorities asked AVXL to apply. If that's true, the authorities may have already pretty much made up their minds. If this were the case, it may be possible that they could approve in substantially less time.

      I'm not saying
      AVXL
      chrismiss_everyday chrismiss_everyday 4 minutes ago
      https://healthmanagement.org/c/hospital/Event/j-p-morgan-43rd-annual-healthcare-conference-jpm-2025

      Maybe they can edit these two paragraphs about less-than-admirable-mab!

      ‘Elsewhere, Biogen CEO Chris Viehbacher discussed his company’s new Alzheimer’s medicine lecanemab
      AVXL
      SSKILLZ1 SSKILLZ1 4 minutes ago
      VMIR (As Of 11/27/24)

      Daily Performance
      Value Microcap Index:+0.97%
      Value Microcap Index Rebalanced:+1.05%

      Overall Performance
      Value Microcap Index: +26.52%
      Value Microcap Index Rebalanced:+30.62%
      na na na na 4 minutes ago
      "You said Canouse is not the one off loading. There are two Canouse, Jeffery & James. Which of the two were you referring two?"

      "I have lock up w them"
      THBD
      pos_stock_hoarder pos_stock_hoarder 4 minutes ago
      A seasonal favorite!
      dstock07734 dstock07734 5 minutes ago
      marty,

      Here is something I wrote for fun. Any comments?
      https://x.com/d_stock07734/status/1861900677930451358
      NWBO
      Slojab Slojab 5 minutes ago
      Look at the 6 month chart. $.015 is not anything to get excited about.
      BMCS
      biowin biowin 5 minutes ago
      Ask Mica Arlette why?

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146912082
      $GROO $GROO 5 minutes ago
      Even in Expert Market, someone is buying. hmmmmmmm
      SANP
      Testpilot Testpilot 5 minutes ago
      I agree
      CRTG
      SPARK SPARK 6 minutes ago
      Just da beginning~
      AUNXF
      al44 al44 8 minutes ago
      We have to wonder if the feds will go after these people as hard as they would if they were targeting democrats.

      ........................al
      SSKILLZ1 SSKILLZ1 8 minutes ago
      ~~COMPX 11/29/2024~~~~~~~

      Previous Close

      19,060.48 -115.10

      18999 SSKILLZ1
      COMP
      TRUISM TRUISM 8 minutes ago
      It appeared as you were flip-flopping...

      Nothing confusing about that.

      At any rate, have a Happy Thanksgiving.

      What is so confusing for you?
      KBLB
      crazy horse 0 crazy horse 0 9 minutes ago
      Thanks Iggy

      The true meaning of Thanksgiving, https://officialrushlimbaugh.com/the-true-story-of-thanksgiving/
      pantherj pantherj 9 minutes ago
      Excellent ideas!
      IFUS
      Schrodingers Cat Schrodingers Cat 10 minutes ago
      Nov 27 short volumes: CODX 34%, FLGT 60%, QDEL 26%, VERU 50%.
      CODX VERU
      Techroemancer Techroemancer 10 minutes ago
      Still can't support any of your claims nor provide any sources as requested? UNsurprising.
      MGON
      100lbStriper 100lbStriper 10 minutes ago
      microby
      3:50 PM

      c16 has now brought in the 2nd time a valuable jury judgement

      the claim describes in just a few words an incredibly valuable system to expand capacity, limited by CC order - on 1 module-, remember?!
      if you sue the big 3, that makes sense,
      NLST
      crazy horse 0 crazy horse 0 10 minutes ago
      Happy Thanksgiving all

      I will be spending time with the ant invasion
      RAlbert RAlbert 12 minutes ago
      ETrade not allowed to buy. Perhaps the same with most brokers. That could be reason for low volume.
      ELAB
      TheDane TheDane 13 minutes ago
      I’m seeing $40 in the near future. 2024!
      IONQ

      Your Recent History

      NASDAQ
      MNLO
      Menlo Therapeutics
      BIT
      UC5CCR
      Unicredit Bank
      BIT
      UV8C90
      UniCredit Bank
      BIT
      UC41GN
      Unicredit Bank
      Delayed Upgrade Clock